[Form 4] CVRx, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CVRx, Inc. director Joseph P. Slattery reported compensation-related equity grants. He received 8,720 shares of Common Stock at no cost and a stock option for 11,182 shares with an exercise price of $5.43 per share, expiring on June 1, 2036. The option vests on the earlier of June 1, 2027 or the company’s 2027 annual meeting of stockholders. After these grants, Slattery directly holds 39,365 Common shares. These are awards, not open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
SLATTERY JOSEPH P
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 11,182 | $0.00 | -- |
| Grant/Award | Common Stock | 8,720 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 11,182 shares (Direct, null);
Common Stock — 39,365 shares (Direct, null)
Footnotes (1)
- [object Object]
FAQ
What insider transactions did CVRx (CVRX) report for Joseph P. Slattery?
CVRx reported that director Joseph P. Slattery received 8,720 shares of Common Stock and a stock option for 11,182 shares as equity compensation. These Form 4 transactions reflect awards, not open-market buying or selling of CVRx shares.
What are the key terms of Joseph P. Slattery’s new CVRx stock option?
The new CVRx stock option covers 11,182 shares of Common Stock at an exercise price of $5.43 per share. It expires on June 1, 2036 and represents a long-dated incentive tied to future company performance and stock price.
When does Joseph P. Slattery’s CVRx stock option vest?
The stock option granted to Joseph P. Slattery vests on the earlier of June 1, 2027 or CVRx’s 2027 annual meeting of stockholders. This vesting schedule links his compensation to continued board service through that date.